当前位置: 首页 > 期刊 > 《医学新知杂志》 > 20122
编号:13756117
丙种球蛋白佐治老年重症肺炎的临床疗效
http://www.100md.com 2012年2月1日 《医学新知·综合版》 20122
临床疗效【中国分类号】R563.1【文献标识码】A【文章编号】1004-5511(2012)0
     (四川省科学城医院四川绵阳621900)【摘要】目的:评价大剂量丙种球蛋白佐治老年重症肺炎的临床疗效及安全性。方法:将60例老年重症肺炎患者随机分为2组,各30例,治疗组予以常规治疗的基础上加用丙种球蛋白治疗,对照组予以常规治疗,对两组病人的临床症状、体征、呼吸衰竭改善情况及临床疗效进行评价。结果:治疗组临床疗效明显优于对照组,在退热时间、咳嗽与咯痰缓解时间、肺部啰音消失时间、痰菌阴转时间、平均住院时间均较对照组明显缩短。结论:静脉注射丙种球蛋白能有效、安全的辅助治疗老年重症肺炎。【关键词】丙种球蛋白;老年重症肺炎;临床疗效【中国分类号】R563.1【文献标识码】A【文章编号】1004-5511(2012)04-0082-01 【Abstract】Objective:To assess the effectiveness and safetyof immunoglobulin for elder patients with severe pneumonia. Methods: 60 elder elderpatients with severe pneumonia were randomly assigned to 2 groups. Patients in theexperimental group were treated using immunoglobulin combined with conventionaltreatment, while the control group using conventional treatment only. The outcomeassessment was clinical symptoms, signs, improvement of respiration failure.Results: The improvement in experimental group is better than control group.The time of abatement of fever, cough and cough up phlegm, rhonchi and transversetime of phlegm bacteria, time of inpatient treatment were shorter than controlgroup. Conclusion: Injection of immunoglobulin in vein is effective and safefor elder patients with severe pneumonia.【Keywords】immunoglobulin, elder patients with severe pneumonia, effectiveness肺炎是老年人的常见病 ......

您现在查看是摘要页,全文长 5904 字符